OngoingEUCTR 2017-001170-42
This study is ongoing in the United Kingdom, in Germany, and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase for Schizophrenia.
SchizophreniaOther
- Countries
- United Kingdom, Germany, Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
CompletedEUCTR 2017-001168-39
This study is completed in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
SchizophreniaOther
- Countries
- United Kingdom, Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
OngoingEUCTR 2017-001169-26
This study is ongoing in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
SchizophreniaOther
- Countries
- United Kingdom, Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
Active Not RecruitingNCT05805176
This study is active but not recruiting in the United States. It is testing Guided ADHD Therapy for ADHD.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Lumos Labs, Inc.
- Condition
- ADHD
CompletedNCT06296784
This study is completed. It focuses on bipolarity and currently lists study information in Italy.
BipolarityOtherOver 18 Years
- Countries
- Italy
- Sponsor
- University of Cagliari
- Condition
- Bipolarity
CompletedNCT01012622
This study is completed in Global. It is testing osmotic Release Oral System Methylphenidate for ADHD.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- Global
- Sponsor
- Janssen Korea, Ltd., Korea
- Condition
- ADHD
CompletedNCT05685732
This study is completed in the United States. It focuses on ADHD.
ADHDOtherFrom 4 Years to 12 Years
- Countries
- United States
- Sponsor
- Corium, Inc.
- Condition
- ADHD
CompletedNCT00460512
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- France, United Kingdom, Switzerland, ...
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia
Active Not RecruitingNCT05990075
This study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Depression
CompletedNCT01455961
This study is completed in Global. It is testing clinical Practice Treatment for Bipolarity.
BipolarityOther
- Countries
- Global
- Sponsor
- AstraZeneca
- Condition
- Bipolarity
CompletedNCT06417918
This study is completed. It focuses on mental health and currently lists study information in Kenya.
Mental healthOtherOver 8 Years
- Countries
- Kenya
- Sponsor
- Duke University
- Condition
- Mental health
CompletedNCT03360201
This study is completed. It focuses on mental health and currently lists study information in Kenya.
Mental healthOtherOver 8 Years
- Countries
- Kenya
- Sponsor
- Duke University
- Condition
- Mental health